Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issuesAnna Porwit, Arjan A. van de Loosdrecht, Canan Alhan et al.|Cytometry Part B Clinical Cytometry|2022Cited by 50
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European <scp>LeukemiaNet</scp>Vincent H. J. van der Velden, Arjan van de Loosdrecht, Frank Preijers et al.|Cytometry Part B Clinical Cytometry|2021Cited by 44
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European <scp>LeukemiaNet</scp> International <scp>MDS‐Flow</scp> Cytometry Working GroupArjan A. van de Loosdrecht, Robin Ireland, Wolfgang Kern et al.|Cytometry Part B Clinical Cytometry|2021Cited by 38
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the<scp>ELN iMDS</scp>flow working groupWolfgang Kern, Arjan van de Loosdrecht, Theresia M. Westers et al.|Cytometry Part B Clinical Cytometry|2022Cited by 30
Multicenter Prospective Evaluation of Diagnostic Potential of Flow Cytometric Aberrancies in Myelodysplastic SyndromesWolfgang Kern, Arjan A. van de Loosdrecht, Theresia M. Westers et al.|Blood|2021Cited by 0